Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-05-16
2006-05-16
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S626000, C514S454000, C514S651000
Reexamination Certificate
active
07045549
ABSTRACT:
Methods are provided for use in treating humans suffering from irritable bowel syndrome. In the subject methods, an effective amount of a nerve-acting agent, e.g., lidocaine, topiramate, mexiletine and gabapentin, etc., is administered to a human suffering from irritable bowel syndrome. Also provided are pharmaceutical compositions and kits for use in practicing the subject methods.
REFERENCES:
patent: 5840332 (1998-11-01), Lerner et al.
patent: 5900233 (1999-05-01), Day
patent: 5965557 (1999-10-01), Asano et al.
patent: 6127418 (2000-10-01), Bueno et al.
patent: 6194382 (2001-02-01), Crain et al.
patent: 6203797 (2001-03-01), Perry
patent: 6228040 (2001-05-01), Craine
patent: 6284770 (2001-09-01), Mangel et al.
patent: 6297226 (2001-10-01), Glasky
patent: WO 00/50027 (2000-08-01), None
Takahiro, Jimi, 121CA:99838. 1992.
Elhakin et al, 132CA:303398, 2000.
Lundgren et al, 132CA:206290. 2000.
Smith et al, 32CA: 1329, 1937.
Kralt et al, 65CA:89966, 1966.
Richekson et al, 90CA:145570, 1978.
Martos et al, 105CA:146060, 1986.
Goodman and Gillman's 9thedition, Hardman et alEds., McGraw-Hill, New York, 1995, p. 157.
Bueno et al. Phathobiology of visceral Pain: Molecular mechanisms and Therapeutic implications, Am J. Physiol. Gastrointest liver physiol. 2000, vol. 278: pp. G670-G676.
Pace et al. “Therapy of irritable Bowel syndrome-An overview,” Digestion 1995, vol. 56 pp. 433-442.
Physicians' Desk Reference, 55 Edition. 2001, TOPAMAX pp. 2392, 2398.
Physicians' Desk Reference, 51 Edition. 1997, MEXITIL, p. 684.
“Irritable Bowel Syndrome,” Apr. 2003,NIH web site: http://digestive.niddk.nih.gov/ddieases/pubs/ibs.
Cintron, et al. “Nerve agents in treating visceral pain”,Abstracts, Int'l Association for the Study of Pain, (2002): 146.
Cintron and Gaeta, Abstracts from Society for Neuroscience (2000) 26:855.2.
Cintron and Gaeta, Neuropathic Agents in the Treatment of Chronic Abdominal Pain Due to Irritable Bowel Syndrome, poster presented Nov. 9, 2000.
Cintron Lynn
Gaeta Raymond R.
Morrison & Foerster / LLP
The Board of Trustees of the Leland Stanford Jr. University
Wang Shengjun
LandOfFree
Treatment of symptoms associated with irritable bowel syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of symptoms associated with irritable bowel syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of symptoms associated with irritable bowel syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3608593